글로벌 항코시디아제 시장 – 2030년까지의 산업 동향 및 예측

항코시디아제 시장 분석 및 규모

최근 몇 년 동안 개, 고양이, 심지어 말을 포함한 애완동물을 인간의 동반자로 받아들이는 일이 크게 늘고 있습니다. 2022년 1월 킹스데일 동물 병원의 데이터에 따르면 코시디아는 개에서 가장 흔히 발견되는 장내 기생충 중 하나이며, 코시디아 발생률은 개에서 50%이며 발생률에 차이가 있습니다.

Data Bridge Market Research는 2023-2030년 예측 기간 동안 글로벌 항코시디움 약물 시장의 성장률을 분석합니다. 글로벌 항코시디움 약물 시장의 예상 CAGR은 언급된 예측 기간 동안 약 9.2%인 경향이 있습니다. 이 시장은 2022년에 1,242.48백만 달러로 평가되었으며 2030년까지 3,103.95백만 달러로 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

항코시디아제 시장 범위 및 세분화

Market Definition

Coccidiosis is caused due to single-celled parasites (protozoa) called Eimeria, which undergo a simple gut life cycle. Any such drug which is used to combat the progression of coccidiosis in birds or animals, both non-food producing and food-producing, is known as an anticoccidial.  Its symptoms include weight loss, feces containing mucus or blood, dehydration, mild intermittent to severe diarrhea, and decreased breeding.

Global Anti-Coccidial Drugs Market Dynamics

Drivers

• Increasing share of animal ownership

Due to the promising economic condition, the highly developed economies represent a major large share of companion animal ownership. For instance, the Pet Food Manufacturers Association reported that in 2021, 17 million (59% of) households in the U.K. owned pets. These pet owners are more worried and aware of the safety of their pets. This creates an opportunity to diagnose fungal and bacterial diseases such as coccidiosis, which is an infection that is caused by the fungus coccidioides immitis among animals. This is projected to contribute to the overall market growth during the forecast period.  

• Rising expenditure on pet healthcare

Pet owners are investing in their pets hugely, such as in health insurance for pets, leading to rising expenditure on their health, thus acting as a major driver for market growth. For instance, according to the North American Pet Health Insurance Association (NAPHIA), around 4.41 million pets were insured in North America at the end of 2021. Furthermore, as per American Pet Products Association, USD 123.6 billion was spent on pets and animals in the U.S. in 2021, which augmented from about USD 99.0 billion in 2020. This expenditure by pet owners is likely to boost market growth over the forecast period.

Opportunities

• The growing burden of coccidiosis in target animals

The wide prevcalence of coccidiosis among the target animals of specific age demands the wide availability of the anticoccidial drugs. For instance, Eimeria is a genus of apicomplexan parasites, that includes several species capable of causing the disease coccidiosis in animals such as dogs, cattle, poultry, cats, and smaller ruminants such as sheep and goats. According to the research article "Coccidiosis of Cattle" published in August 2022, approximately 20 or more Eimeria species have been identified in cattle feces worldwide. Thus, this factor creates more opportunities for market growth.

• Increasing prevalence of isospora species

According to the Merck and Co. Inc. data updated in August 2022 on "Coccidiosis of Cats and Dogs", the isospora species is a common coccidiosis of cats and dogs. Approximately every cat gets infected by isospora felis in its lifetime. Moreover, as per the source mentioned above, coccidiosis usually occurs in young animals in facilities with potential contamination and  high population. Thus, this disease may become a problem in breeding or boarding catteries and kennels. This burden of coccidiosis among companion animals creates many different opportunities for developing anticoccidial drugs. This is projected to contribute to segment growth.

 Restraints/Challenges

• Limited studies and surveys

There are very limited studies and surveys that are hampering the growth of the market. Not many studies and awareness have been spread about this disease, and thus, this hampers the market's growth.

• High cost of drugs

The huge expenditure associated with anti-coccidial medications hampers the market growth. Different polyether antibiotics or ionophores, combination anti-coccidial drugs are of high cost which restricts the growth of the market.

This global anti-coccidial drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global anti-coccidial drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Anti-Coccidial Drugs Market

The outbreak of COVID-19 showed an adverse impact on the global anti-coccidial drugs market . According to the article "The Initial Months of COVID-19: Dog Owners' Veterinary-Related Concerns," published in February 2021, dog owners feared that COVID-19 infection might lead to a decrease in disease diagnoses for pets. Moreover, the study showed that like many other professions, veterinarians were majorly impacted by the onset of COVID-19 in the initial phase of the pandemic. Thus, standard practices such as routine animal checkups, diagnoses, and surgeries were disturbed. These reduced services lowered the coccidiosis diagnosis, therefore, hampering the market growth.

But, in the post-pandemic era, poultry consumption and the adoption of companion animals increased. This led to a higher demand for diagnosis of poultry coccidiosis and companion animal coccidiosis. Thus, on the basis of above factors, the COVID-19 pandemic considerably impacted the market.

Recent Developments:

• In March 2022, Amlan International developed two new natural alternatives to antibiotics for poultry and livestock, such as Phylox Feed and NeutraPath. Phylox Feed is a natural alternative to anticoccidial drugs and vaccines, that can help producers to increase profitability.

Global Anti-Coccidial Drugs Market Scope

The global anti-coccidial drugs market is segmented on the basis of type, animals, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Synthetic Drugs
• Polyether Antibiotics or Ionophores
• Combination Anti-Coccidial Drugs
• Others

Animals

• Swine
• Fish
• Cattle
• Poultry
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Anti-Coccidial Drugs Market Regional Analysis/Insights

The global anti-coccidial drugs market is analysed and market size insights and trends are provided by type, animals, distribution channel and end-user as referenced above.

The major countries covered in the global anti-coccidial drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing positive growth for the global anticoccidial drugs market throughout the forecasted period due to increased healthcare and R&D expenditure and the presence of skilled professionals.

Asia-Pacific dominates the market due to increased poultry farming and increased awareness for anti-coccidial drugs through advertisement and media and rapidly improving healthcare infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Anti-coccidial Drugs Market Share Analysis

글로벌 항코시디움 약물 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 항코시디움 약물 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 항코시듐제 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Impextraco NV(벨기에)
• 베토퀴놀(프랑스)
• Phibro Animal Health Corporation (미국)
• Huvepharma(불가리아)
• 비르박(프랑스)
• Bayer AG(독일)
• Merck & Co., Inc(미국),
• 노바티스 AG(스위스).
• 조에티스(미국)
• 엘란코(미국)
• 세바(프랑스).
• ProBioGen AG(독일)

SKU-56336